The influence of proton pump inhibitors and other commonly used medication on the gut microbiota-Reference-Cited by-同舟云学术

The influence of proton pump inhibitors and other commonly used medication on the gut microbiota

Published:2017-01-24 Issue:4 Volume:8 Page:351-358
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Imhann Floris¹²,Vich Vila Arnau¹²,Bonder Marc Jan²,Lopez Manosalva Ailine G.³^ORCID,Koonen Debby P.Y.³,Fu Jingyuan³,Wijmenga Cisca²^ORCID,Zhernakova Alexandra²,Weersma Rinse K.¹

Affiliation:

1. University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, the Netherlands

2. University of Groningen and University Medical Center Groningen Department of Genetics, Groningen, the Netherlands

3. University of Groningen and University Medical Center Groningen, Groningen Department of Pediatrics, Groningen, the Netherlands

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),Gastroenterology,Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2017.1284732

Reference40 articles.

1. Gastro-oesophageal reflux disease

2. Potential association between the recent increase in campylobacteriosis incidence in the Netherlands and proton-pump inhibitor use – an ecological study

3. Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression

4. Clostridium difficile -Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis

5. Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association and Mechanisms of Proton Pump Inhibitors Use with Type-2 Diabetes Mellitus Incidence in Adults: A Systemic Review and Meta-Analysis;Current Diabetes Reviews;2024-10

2. Spatial Variation of the Gastrointestinal Microbiota in Response to Long‐Term Administration of Vonoprazan in Mice With High Risk of Gastric Cancer;Helicobacter;2024-07

3. The Impact of Proton Pump Inhibitors on the Efficacy of Immune Checkpoint Inhibitor Combinations in Patients with HBV-Associated Advanced Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-07

4. Multidisciplinary Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: CONFOR;Euroasian journal of hepato-gastroenterology;2024-06-12

5. Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population‐based cohort study;Acta Obstetricia et Gynecologica Scandinavica;2024-06-03